SRI Krishna Pharmaceuticals Limited — Paracetamol Exporter Profile
Indian Pharmaceutical Exporter · #5 for Paracetamol · $10.6M export value · DGFT Verified
SRI Krishna Pharmaceuticals Limited is the #5 Indian exporter of Paracetamol with $10.6M in export value and 212 verified shipments. SRI Krishna Pharmaceuticals Limited holds a 3.0% market share in Paracetamol exports across 14 countries. The company exports 6 pharmaceutical products worth $31.4M across 3 therapeutic categories.
SRI Krishna Pharmaceuticals Limited — Paracetamol Export Profile: Buyers & Destinations
Where Does SRI Krishna Pharmaceuticals Limited Export Paracetamol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $6.8M | 183 | 30.8% |
| SPAIN | $5.5M | 138 | 25.0% |
| MEXICO | $3.0M | 66 | 13.5% |
| GERMANY | $2.2M | 72 | 9.8% |
| UNITED ARAB EMIRATES | $1.1M | 24 | 5.1% |
| UNITED KINGDOM | $814.7K | 42 | 3.7% |
| JORDAN | $479.0K | 12 | 2.2% |
| OMAN | $478.2K | 11 | 2.2% |
| MALAYSIA | $403.2K | 12 | 1.8% |
| CANADA | $400.0K | 8 | 1.8% |
SRI Krishna Pharmaceuticals Limited exports Paracetamol to 20 countries. The largest destination is AUSTRALIA accounting for 30.8% of SRI Krishna Pharmaceuticals Limited's Paracetamol shipments, followed by SPAIN (25.0%) and MEXICO (13.5%). These destinations reflect SRI Krishna Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Paracetamol from SRI Krishna Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO, | JORDAN | $3.2M | 96 |
| APOTEX PTY LTD | AUSTRALIA | $656.2K | 18 |
| TO HEALTHCARE LOGISTICSC O APOTEX PTY LIMITED | AUSTRALIA | $633.4K | 18 |
| TO HELM DE | MEXICO | $497.4K | 12 |
| TO SAG MANUFACTURING SLUMANUFACTURING PLANT | SPAIN | $350.0K | 7 |
| FAIRMED HEALTHCARE GMBH | GERMANY | $338.6K | 26 |
| FARMALIDER S.A. | SPAIN | $313.6K | 8 |
| TO US PHARMACIA SP ZOOZIEBICKA | POLAND | $250.0K | 5 |
| HELM DE MEXICO, S.A. | MEXICO | $250.0K | 5 |
| HEALTHCARE LOGISTICS | AUSTRALIA | $219.7K | 6 |
SRI Krishna Pharmaceuticals Limited supplies Paracetamol to 64 buyers globally. The largest buyer is TO, (JORDAN), followed by APOTEX PTY LTD (AUSTRALIA) and TO HEALTHCARE LOGISTICSC O APOTEX PTY LIMITED (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Paracetamol Export Value and How Much Does SRI Krishna Pharmaceuticals Limited Contribute?
India exported $157.4M worth of Paracetamol through 15,000 shipments from 870 suppliers to 170 countries, serving 2,197 buyers globally. SRI Krishna Pharmaceuticals Limited contributes $10.6M to this total, accounting for 3.0% of India's Paracetamol exports. SRI Krishna Pharmaceuticals Limited ships Paracetamol to 20 countries through 64 buyers.
What Is the Average Shipment Value for SRI Krishna Pharmaceuticals Limited's Paracetamol Exports?
SRI Krishna Pharmaceuticals Limited's average Paracetamol shipment value is $50.0K per consignment, based on 212 shipments totaling $10.6M. The largest destination is AUSTRALIA (30.8% of SRI Krishna Pharmaceuticals Limited's Paracetamol exports).
How Does SRI Krishna Pharmaceuticals Limited Compare to Other Indian Paracetamol Exporters?
SRI Krishna Pharmaceuticals Limited ranks #5 among 870 Indian Paracetamol exporters with a 3.0% market share. The top 3 exporters are ADCOCK INGRAM LIMITED ($27.7M), IPCA LABORATORIES LIMITED ($23.3M), INDOCO REMEDIES LIMITED ($21.6M). SRI Krishna Pharmaceuticals Limited processed 212 shipments to 14 destination countries.
What Paracetamol Formulations Does SRI Krishna Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FINISHED DOSAGE FORM-PARACETAMOL MODIFIE | $2.1M | 47 |
| PARACETAMOL GRANULES DC 90% (KRISOPAP-90F) | $700.0K | 14 |
| PARACETAMOL GRANULES DC GRADE 90% [KRISOPAP-90C] | $700.0K | 14 |
| PARACETAMOL GRANULES DC GRADE 90% [KRISOPAP-90F] | $614.0K | 13 |
| PARACETAMOL GRANULES DC GRADE (PARACETAM | $479.3K | 10 |
| PHARMACEUTICAL PRODUCT-PARACETAMOL MODIF | $370.1K | 11 |
| PARACETAMOL GRANULES DC GRADE (ACETAMINO | $328.1K | 10 |
| PARACETAMOL GRANULES DC GRADE 90% | $300.1K | 7 |
| PARACETAMOL GRANULES DC GRADE 90% (PARACETAMOLGRANULES DC 90%)[KRISOPAP-90F] | $283.0K | 7 |
| PARACETAMOL GRANULES DC GRADE(ACETAMINOP | $250.0K | 5 |
SRI Krishna Pharmaceuticals Limited exports 319 distinct Paracetamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FINISHED DOSAGE FORM-PARACETAMOL MODIFIE with 47 shipments worth $2.1M.
Regulatory Requirements: Exporting Paracetamol to Key Markets
What SRI Krishna Pharmaceuticals Limited must comply with to export Paracetamol to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Paracetamol Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | ZENTIVA PRIVATE LIMITED | $12.3M | 321 | 5 | $38.4K |
| 4 | GRANULES INDIA LIMITED | $11.2M | 224 | 21 | $50.0K |
| 5 | SRI KRISHNA PHARMACEUTICALS LIMITED ★ | $10.6M | 212 | 14 | $50.0K |
| 7 | MEDREICH LIMITED | $8.1M | 241 | 10 | $33.8K |
| 9 | SOCOMED PHARMA PRIVATE LIMITED | $6.9M | 244 | 13 | $28.2K |
SRI Krishna Pharmaceuticals Limited ranks #5 among 870 Indian Paracetamol exporters. Average shipment value of $50.0K compared to the market average of $180.9K. The closest competitors by value are ZENTIVA PRIVATE LIMITED and GRANULES INDIA LIMITED.
Which Indian Ports Ship Paracetamol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 4,107 | 27.4% |
| BANGALORE ICD (INWFD6) | 1,125 | 7.5% |
| JNPT | 959 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 763 | 5.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 717 | 4.8% |
| AHEMDABAD ICD (INSBI6) | 620 | 4.1% |
| MUNDRA SEA (INMUN1) | 480 | 3.2% |
| CHENNAI SEA (INMAA1) | 410 | 2.7% |
What Other Analgesics & Antipyretics Products Does SRI Krishna Pharmaceuticals Limited Export?
SRI Krishna Pharmaceuticals Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Paracetamol Exports
Recent geopolitical tensions, notably the Israel-Iran conflict, have disrupted key shipping routes such as the Red Sea, leading to increased freight costs and extended transit times for Indian pharmaceutical exporters. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has highlighted potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. For SKPL, which relies on timely deliveries to maintain product efficacy, these logistical challenges necessitate strategic adjustments, including exploring alternative shipping routes and bolstering regional distribution networks.
In the US market, recent tariff implementations have introduced additional complexities for Indian exporters. While generic drugs have been exempted from certain tariffs, the overall trade environment remains uncertain. SKPL must remain vigilant, monitoring policy shifts and adapting its export strategies accordingly to maintain its competitive edge.
The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, presents new opportunities for SKPL in European markets. By eliminating or reducing tariffs on pharmaceutical products, the agreement facilitates smoother market entry, allowing SKPL to expand its footprint in EFTA member countries.
SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with bodies like the US FDA increasing inspections to ensure compliance with Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining consistent quality standards. Instances of substandard products have prompted calls for stricter oversight. For SKPL, maintaining rigorous quality control measures and staying abreast of evolving regulatory requirements are imperative to sustain its export credentials and market reputation.
About SRI Krishna Pharmaceuticals Limited
SRI Krishna Pharmaceuticals Limited exports 6 products worth $31.4M. Beyond Paracetamol, top products include Amino, Acetaminophen, Tramadol, Loperamide, Aspirin. View the complete SRI Krishna Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paracetamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paracetamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SRI Krishna Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 598 individual customs records matching SRI Krishna Pharmaceuticals Limited exporting Paracetamol, covering 319 formulations to 20 countries via 64 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paracetamol Export Data from SRI Krishna Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SRI Krishna Pharmaceuticals Limited's Paracetamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SRI Krishna Pharmaceuticals Limited
Full Company Profile →
6 products · $31.4M total trade · 3 categories
Paracetamol Stats
Company Overview
Top Products by SRI Krishna Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SRI Krishna Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paracetamol. For current shipment-level data, contact TransData Nexus.